This is an HTML version of an attachment to the Freedom of Information request 'Review into atrial fibrillation and atrial flutter'.



 
 
 

 
Other investigations The investigations previously notified in regard to Chronic 
lymphocytic leukaemia/small lymphocytic lymphoma, Creutzfeldt-Jakob disease, 
malignant neoplasm of the anus and anal canal, epilepsy, steatohepatitis ,allergic contact 
dermatitis, conjunctivitis, asthma and ‘pack year’ definitions were finalised at the 
meeting.  
 
The Authority, following discussion, deferred until a subsequent meeting the investigations 
previously notified concerning atrial fibrillation and atrial flutter, periodic limb movement 
disorder and malignant neoplasm of the prostate.  
 
 
INSTRUMENTS 
 
After consideration of the information available to it as set out in Schedule 1 in respect of 
investigations previously notified, as well as an assessment of the compatibility of the new 
Instruments with human rights and freedoms recognised in relevant international instruments, 
the Authority agreed to determine new SOPs referred to as follows: 
 
NEW INSTRUMENT TITLE 
VEA PROVISION 
94/2022 Veterans’ Entitlements 
Subsections 196B(2), 196B(3) 
(Statements of principles- ‘one pack year’ definition) 
and 196B(8) 
Amendment determination 2022  
 
 
After consideration of the information available to it as set out in Schedule 1 in respect of 
investigations previously notified concerning the contents of SOPs, as well as an assessment 
of the compatibility of the new Instruments with human rights and freedoms recognised in 
relevant international instruments, the Authority revoked the following SOPs and agreed to 
determine new SOPs as follows:  
 
REVOKED INSTRUMENT 
NEW INSTRUMENT 
VEA 
TITLE 
TITLE 
PROVISION 
No. 84 of 2014  [Statement of 
Statement of Principles 
Subsection 
Principles under subsection 196B(2) 
concerning mature B-cell 
196B(2) 
concerning Chronic lymphocytic 
lymphoid leukaemia and small  Subsection 
leukaemia/small lymphocytic 
lymphocytic lymphoma   
196B(8) 
lymphoma] 
(Reasonable Hypothesis) No. 
78 of 2022  
No.85 of 2014 [Statement of 
Statement of Principles 
Subsection 
Principles under subsection 196B(3) 
concerning mature B-cell 
196B(3) 
concerning Chronic lymphocytic 
lymphoid leukaemia and small  Subsection 
leukaemia/small lymphocytic 
lymphocytic lymphoma   
196B(8) 
lymphoma] 
(Balance of Probabilities) No. 
79 of 2022  
Page 2 of 6 
 

 
REVOKED INSTRUMENT 
NEW INSTRUMENT 
VEA 
TITLE 
TITLE 
PROVISION 
No.  76 of 2014 [Statement of 
Statement of Principles 
Subsection 
Principles under subsection 196B(2) 
concerning Creutzfeld-Jakob 
196B(2) 
concerning Creutzfeld-Jakob disease]  disease (Reasonable 
Subsection 
Hypothesis) No.80 of 2022 
196B(8) 
No. 77 of 2014 [Statement of 
Statement of Principles 
Subsection 
Principles under subsection 196B(3) 
concerning Creutzfeld-Jakob 
196B(3) 
concerning Creutzfeld-Jakob disease]  disease (Balance of 
Subsection 
Probabilities) No 81 of 2022 
196B(8) 
 No.51  of 2013 [Statement of 
Statement of Principles 
Subsection 
Principles under subsection 196B(2) 
concerning malignant 
196B(2) 
concerning malignant neoplasm of 
neoplasm of the anus and anal 
Subsection 
the anus and anal canal] 
canal (Reasonable Hypothesis)  196B(8) 
No.82 of 2022 
No. 52  of 2013 [Statement of 
Statement of Principles 
Subsection 
Principles under subsection 196B(3) 
concerning malignant 
196B(3) 
concerning malignant neoplasm of 
neoplasm of the anus and anal 
Subsection 
the anus and anal canal] 
canal (Balance of 
196B(8) 
Probabilities) No.83 of 2022 
No. 75 of 2013 [Statement of 
Statement of Principles 
Subsection 
Principles under subsection 196B(2) 
concerning epilepsy 
196B(2) 
concerning epilepsy ] 
(Reasonable Hypothesis) No. 
Subsection 
84 of 2022 
196B(8) 
No. 76 of 2013 [Statement of 
Statement of Principles 
Subsection 
Principles under subsection 196B(3) 
concerning epilepsy (Balance 
196B(3) 
concerning epilepsy  ] 
of Probabilities) No.85 of 2022  Subsection 
196B(8) 
No.  79 of 2013 [Statement of 
Statement of Principles 
Subsection 
Principles under subsection 196B(2) 
concerning steatohepatitis 
196B(2) 
concerning steatohepatitis ] 
(Reasonable Hypothesis) No. 
Subsection 
86 of 2022 
196B(8) 
No. 80 of 2013 [Statement of 
Statement of Principles 
Subsection 
Principles under subsection 196B(3) 
concerning steatohepatitis 
196B(3) 
concerning steatohepatitis ] 
(Balance of Probabilities) No. 
Subsection 
87 of 2022 
196B(8) 
 
After consideration of the information available to it as set out in Schedule 1 in respect of 
investigations previously notified concerning the contents of the following SOPs, as well as an 
assessment of the compatibility of the new Instruments with human rights and freedoms 
recognised in relevant international instruments, the Authority determined the following new 
instruments amending these SOPs: 
 
INSTRUMENT TITLE 
AMENDING 
VEA 
INSTRUMENT TITLE 
PROVISION 
No. 1 of 2021 [Statement of Principles  Amendment Statement of 
Subsection 
under subsection 196B(2) concerning  Principles concerning allergic 
196B(2) 
allergic contact dermatitis] 
contact dermatitis (Reasonable 
Subsection 
Hypothesis) No.88 of 2022 
196B(8) 
Page 3 of 6 
 



 
SCHEDULE 1 
 
Information available to the Repatriation Medical Authority (s196K of the VEA) 
 
INSTRUMENT TITLE 
INFORMATION CONSIDERED 
STATEMENTS OF PRINCIPLES 
 Briefing paper in relation to the investigation into 
CONCERNING MATURE B-CELL 
mature B-cell lymphoid leukaemia and small 
LYMPHOID LEUKAEMIA AND 
lymphocytic lymphoma  prepared by the RMA 
SMALL LYMPHOCYTIC 
Secretariat; 
LYMPHOMA   NOS. 78 and 79 OF 
 Comparison table in relation to the investigation into 
2022  
mature B-cell lymphoid leukaemia and small 
lymphocytic lymphoma  prepared by the RMA 
Secretariat;  
 Submissions & other information received in relation 
to the investigation into mature B-cell lymphoid 
leukaemia and small lymphocytic lymphoma  
 Reference list in relation to the investigation into 
mature B-cell lymphoid leukaemia and small 
lymphocytic lymphoma   .  
STATEMENTS OF PRINCIPLES 
 Briefing paper in relation to the investigation into 
CONCERNING CREUTZFELDT-
Creutzfeldt-Jakob disease prepared by the RMA 
JAKOB DISEASE NOS. 80 AND 81 
Secretariat; 
OF 2022  
 Comparison table in relation to the investigation into 
Creutzfeldt-Jakob disease prepared by the RMA 
Secretariat;  
 Submissions & other information received in relation 
to the investigation into Creutzfeldt-Jakob disease;  
 Reference list in relation to the investigation into 
Creutzfeldt-Jakob disease.  
STATEMENT OF PRINCIPLES 
 Briefing paper in relation to the investigation into 
CONCERNING MALIGNANT 
malignant neoplasm of the anus and anal canal 
NEOPLASM OF THE ANUS AND 
prepared by the RMA Secretariat; 
ANAL CANAL NOS. 82  AND 83 
 Comparison table in relation to the investigation into 
OF 2022  
malignant neoplasm of the anus and anal canal 
prepared by the RMA Secretariat;  
 Submissions & other information received in relation 
to the investigation into malignant neoplasm of the 
anus and anal canal;  
 Reference list in relation to the investigation into 
malignant neoplasm of the anus and anal canal. 
STATEMENT OF PRINCIPLES 
 Briefing paper in relation to the investigation into 
CONCERNING EPILEPSY NOS. 84 
epilepsy prepared by the RMA Secretariat; 
AND 85 OF 2022  
 Comparison table in relation to the investigation into 
epilepsy prepared by the RMA Secretariat;  
 Submissions & other information received in relation 
to the investigation into epilepsy;  
 Reference list in relation to the investigation into 
epilepsy. 
Page 5 of 6 
 

 
INSTRUMENT TITLE 
INFORMATION CONSIDERED 
STATEMENT OF PRINCIPLES 
 Briefing paper in relation to the investigation into 
CONCERNING 
steatohepatitis prepared by the RMA Secretariat; 
STEATOHEPATITIS NOS. 86 AND   Comparison table in relation to the investigation into 
87 OF 2022  
steatohepatitis prepared by the RMA Secretariat;  
 Submissions & other information received in relation 
to the investigation into steatohepatitis ;  
 Reference list in relation to the investigation into 
steatohepatitis . 
STATEMENT OF PRINCIPLES 
 Briefing paper in relation to the investigation into 
CONCERNING ALLERGIC 
allergic contact dermatitis prepared by the RMA 
CONTACT DERMATITIS NOS. 88 
Secretariat; 
AND 89 OF 2022  
 Comparison table in relation to the investigation into 
allergic contact dermatitis prepared by the RMA 
Secretariat;  
 Submissions & other information received in relation 
to the investigation into allergic contact dermatitis;  
 Reference list in relation to the investigation into 
allergic contact dermatitis. 
STATEMENT OF PRINCIPLES 
 Briefing paper in relation to the investigation into 
CONCERNING CONJUNCTIVITIS 
conjunctivitis prepared by the RMA Secretariat; 
NOS. 90 AND 91 OF 2022 
 Comparison table in relation to the investigation into 
conjunctivitis prepared by the RMA Secretariat;  
 Submissions & other information received in relation 
to the investigation into conjunctivitis;  
 Reference list in relation to the investigation into 
conjunctivitis. 
AMENDMENT STATEMENT OF 
 Briefing paper in relation to the investigation into 
PRINCIPLES CONCERNING 
asthma prepared by the RMA Secretariat; 
ASTHMA NOS. 92 AND 93 OF 
 Comparison table in relation to the investigation into 
2022  
asthma prepared by the RMA Secretariat;  
 Submissions & other information received in relation 
to the investigation into asthma;  
 Reference list in relation to the investigation into 
asthma. 
VETERANS’ ENTITLEMENTS 
 Appendix 1 showing Statements of Principles 
(STATEMENTS OF PRINCIPLES- 
amended  
‘ONE PACK YEAR’ DEFINITION) 
AMENDMENT DETERMINATION 
2022 NO. 94  OF 2022  
 
Page 6 of 6